Trial Profile
A prospective real life study Effect of Reslizumab in patients with severe eosinophilic asthma (SEA)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Nov 2018
Price :
$35
*
At a glance
- Drugs Reslizumab (Primary)
- Indications Asthma
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 01 Nov 2018 New trial record